Healthcare companies are pouring artificial intelligence into prior authorization. Providers now use AI to prepare submissions, collect documentation, and draft appeals. At the same time, payers use algorithms and AI tools to review those requests and manage utilization.
Otter Health thinks both sides may be solving the wrong problem.
On October 15, the startup launched with $8 million in seed funding co-led by Fika Ventures and Evidenced. Slow Ventures, Metrodora, CoFound Partners, Layout Ventures, Patient Capital, and Semper Virens also participated. Otter has built an AI-powered platform that compares clinical decisions with evidence-based standards in real time. Its goal is to help payers and providers manage quality and utilization without forcing every decision through a traditional prior authorization checkpoint.
That distinction makes the company interesting.
Otter is not simply building a faster prior authorization tool. Instead, it is asking why healthcare needs to interrupt so many clinical decisions with an authorization process in the first place.
For pharmacy entrepreneurs, that idea matters far beyond prior authorization. Sometimes the best opportunity is to improve a frustrating workflow. Other times, the better opportunity is to question whether the workflow should exist at all.
The goal was never the authorization form
Prior authorization exists for a reason. Health plans need to manage utilization, reduce unnecessary spending, and confirm that certain services meet clinical criteria before they pay for them.
Over time, however, that oversight process created layers of administrative work. A healthcare professional orders a medication, procedure, referral, or service. The payer asks for more information. Someone gathers the documentation and submits the request. The payer then approves it, denies it, or asks for additional details. A denial may trigger another round of paperwork and appeals.
Technology companies have spent years trying to speed up those steps. AI now gives both sides much more powerful tools.
A provider can assemble an authorization request in seconds. A payer can review more requests with automation. Each side becomes more efficient, yet the same adversarial process remains.
Otter Health CEO Keith Florance described that dynamic to Fierce Healthcare as an AI “arms race” between providers and payers. His argument is that automating prior authorization does not solve the lack of trust underneath it.
That leads to a different question: could healthcare manage utilization without requiring a separate permission step for every decision?
Otter wants the system to evaluate care continuously
Otter’s platform analyzes clinical decisions across areas such as referrals, outpatient procedures, pathway adherence, and care transitions. It compares those decisions with evidence-based standards and shows organizations where practice aligns with those standards and where it varies.
Providers can receive feedback when a decision does not match the evidence or when important documentation is missing. In theory, organizations could use that information to identify which clinicians consistently make evidence-aligned decisions and which situations need closer review.
That changes when utilization management happens.
Traditional prior authorization interrupts a specific decision before care moves forward. Otter instead wants organizations to measure appropriateness continuously and reserve stronger intervention for situations that truly need it.
The company says organizations using its platform have removed prior authorization in selected areas while keeping non-concordant decisions below 5%. Otter also reports that customers identified low-value care that traditional prior authorization had missed. Those results come from the company itself, so they do not yet prove that the model will work broadly across healthcare.
Still, the concept is worth studying because it separates the original goal from the process healthcare currently uses to achieve it.
This is really a lesson in system design
Healthcare entrepreneurs often begin with a visible pain point. They see a process that takes too long, requires too much staff time, or frustrates patients. The natural response is to build technology that makes the process faster.
That approach can create real value. It can also lock the company into the assumptions of the old system.
Consider two ways to approach prior authorization. One entrepreneur may ask how AI can complete the paperwork in 30 seconds instead of 15 minutes. Another may ask why the paperwork exists, what problem it protects against, and whether a different system could achieve the same goal.
The first person is optimizing a workflow. The second is redesigning it.
Pharmacists should pay attention to that distinction because pharmacy contains countless processes that feel permanent only because we have used them for years.
Refill requests move back and forth between pharmacies and prescribers. Formulary exceptions force teams to justify treatments after the prescribing decision. Medication reconciliation exists because different parts of healthcare maintain different medication lists. Specialty prescriptions often travel to one pharmacy before someone discovers that the patient’s benefit requires another.
Each process developed for a reason. However, the current process may not represent the best possible solution.
Pharmacy is full of problems created by missing information
Many frustrating medication workflows exist because two parts of healthcare do not share the same information at the right time.
Benefit verification offers a simple example. A pharmacy or provider checks whether a medication is covered after someone has already made the treatment decision. If that coverage information appeared earlier, some of the downstream work might disappear.
Specialty routing creates a similar problem. A prescription reaches one pharmacy, but the patient’s plan requires another. Staff then transfer or redirect the prescription. Better information at the point of prescribing could prevent the error altogether.
Medication reconciliation also reflects fragmented information. Multiple healthcare organizations may each maintain a different medication list, so someone has to compare them manually and determine which version is correct.
Pharmacists experience these failures constantly. That gives the profession a useful entrepreneurial advantage.
We see where workflows break after one part of healthcare hands a decision to another. We know which problems repeat, which ones waste skilled labor, and which steps genuinely protect patients.
Most people learn to manage that friction.
Entrepreneurs learn to question it.
AI can redesign work, not only accelerate it
Artificial intelligence makes this distinction even more important.
When new technology becomes powerful, organizations naturally apply it to existing tasks. If employees spend hours summarizing records, AI can summarize them. If teams manually review hundreds of cases, an algorithm can help identify the most important ones.
Those uses can save enormous amounts of time.
However, AI can also change the workflow itself.
Otter is trying to do that with utilization management. Instead of using AI only to produce or review the authorization request, the company uses technology to evaluate clinical decisions continuously.
The same principle can apply throughout pharmacy. Rather than asking how AI could process a formulary exception faster, ask whether better information could prevent the exception. Instead of automating calls about drug shortages, ask whether real-time inventory and therapeutic alternatives could guide prescribing earlier.
Specialty pharmacy offers another example. Technology could automate the process of rerouting a prescription after it reaches the wrong pharmacy. A better system might identify the correct dispensing pathway before the prescription leaves the prescriber.
The more powerful question is not always, “What can we automate?”
Sometimes it is, “What work should no longer need to happen?”
Do not remove a process until you understand what it protects
There is one important caution.
Healthcare processes often contain friction because mistakes carry real consequences. Before an entrepreneur removes a workflow, they need to understand what risk that workflow controls.
Prior authorization may frustrate providers, but payers still need a way to identify inappropriate or unnecessary care. Medication verification may slow dispensing, but it protects patients from errors. Clinical review may add another step, but that step may prevent harm.
Otter does not argue that organizations should abandon accountability. Its model attempts to replace routine transaction-by-transaction permission with continuous measurement, evidence-based feedback, and more targeted intervention. Florance has said he sees traditional prior authorization potentially becoming the exception rather than the default.
That principle applies to almost any healthcare redesign.
First, identify the risk that the current process manages. Then build an alternative that controls that risk more effectively.
Removing friction without preserving safety creates a worse system. Removing unnecessary friction while maintaining the protection can create something much better.
Start with the outcome, not the workflow
Pharmacy entrepreneurs can use a simple exercise to think this way.
Choose one process that frustrates you regularly. It might involve prior authorization, benefit verification, formulary exceptions, refill requests, medication reconciliation, specialty routing, or prescriber clarification.
Next, forget the current workflow for a moment and identify the outcome it is supposed to create.
Prior authorization aims to promote appropriate utilization and control unnecessary spending. Medication reconciliation aims to create an accurate medication list. Benefit verification establishes whether and how a treatment is covered. Prescriber clarification resolves uncertainty before a medication reaches the patient.
Once you know the goal, ask whether the existing steps are the only way to achieve it.
That question forces you to separate the problem from the process.
A pharmacist who says, “Prior authorization takes too long,” has identified frustration. A pharmacist who says, “The payer needs confidence that the medication is appropriate, while the prescriber needs treatment to move forward without unnecessary delay,” has identified two needs that a business could potentially solve.
The second framing gives an entrepreneur far more to work with.
Your next business idea may be hiding inside a workflow you hate
Pharmacists sit unusually close to healthcare’s operational failure points.
A prescriber orders a medication, and the pharmacist sees why the patient cannot get it. A payer creates a coverage policy, and the pharmacist sees how that policy behaves at the point of care. A manufacturer launches a support program, and the pharmacist sees whether patients can actually use it. A hospital discharges someone, and the pharmacist sees whether the outpatient medication list makes sense.
Those experiences create valuable market knowledge.
This week, choose one workflow you regularly complain about. Then impose one rule on yourself: you are not allowed to improve it.
You have to eliminate it.
Ask what you would need to build so the process became unnecessary. If prior authorization disappeared, how would the payer know whether treatment remained appropriate? If medication reconciliation disappeared, how would every healthcare professional know what the patient was taking? If specialty routing disappeared, how would the prescription reach the right pharmacy the first time?
Your first idea may be unrealistic. That is fine.
The exercise forces you to think about the outcome instead of the steps healthcare inherited.
The $8 million is funding a hypothesis
Otter Health has not proved that traditional prior authorization can disappear across healthcare. The company remains early, and its current results come from its own customers and reporting.
The $8 million seed round funds a hypothesis: healthcare organizations may be able to maintain strong oversight of quality and utilization without forcing every clinical decision through the same administrative checkpoint.
Fierce Healthcare reports that Otter plans to use the financing to expand into more specialties, scale its platform, and grow its engineering and physician teams. The company currently works with health plans, health systems, and risk-bearing provider groups.
Whether Otter’s specific model succeeds remains to be seen. The entrepreneurial lesson already has value.
Healthcare has plenty of broken processes, and AI gives companies powerful tools to make those processes faster. However, efficiency should not stop us from questioning whether the process still makes sense.
Sometimes the best company will automate the paperwork.
Another company may make the paperwork unnecessary.
For pharmacists who spend every day inside complicated healthcare workflows, that creates a powerful habit of thought. When a process frustrates you, do not only ask how to make it easier. Ask why it exists, what outcome it protects, and what you would have to build so the system no longer needed the process at all.
That is where operational frustration can become an entrepreneurial opportunity.
Resources & Citations
- Otter Health. “Otter Health Launches With $8 Million to Build a New Era of Utilization and Quality Management Beyond Prior Authorization.” October 15, 2026. Company announcement confirming the $8 million seed round, participating investors, Otter’s real-time approach to evidence-based utilization management, and company-reported early results.
- Fierce Healthcare. “As Prior Auth Becomes an AI ‘Arms Race,’ Otter Health Raises $8M for a Different Approach.” October 15, 2026. Independent reporting on Otter Health’s funding, founders, business strategy, current customers, and its argument that automating prior authorization does not resolve the underlying payer-provider conflict.
- Otter Health. “Healthcare’s Future Depends on Shifting Beyond Prior Authorization.” October 27, 2025. Earlier company commentary outlining Otter’s argument for moving from routine prior authorization toward continuous evidence-based utilization management.